Centre for Genomic Regulation

Centre for Genomic Regulation
Name	Centre for Genomic Regulation
Established	2000
Type	Research institute
City	Barcelona
Country	Spain

Centre for Genomic Regulation

The Centre for Genomic Regulation is a biomedical research institute based in Barcelona, Spain, focused on genomics, molecular biology, and computational biology. It operates within the biomedical research landscape alongside institutions such as European Molecular Biology Laboratory, Max Planck Society, Howard Hughes Medical Institute, Wellcome Trust, and Institut Pasteur. The institute engages with regional and international actors including Catalonia, Spain, European Union, Horizon 2020, and European Research Council.

History

Founded in 2000, the institute emerged during a period influenced by initiatives like the Human Genome Project, Genomics England, National Human Genome Research Institute, and the rise of large-scale sequencing exemplified by Illumina and Roche Diagnostics. Early funding and establishment involved stakeholders comparable to Spanish National Research Council, Catalan Institute of Health, Fundació "la Caixa", and regional authorities such as Barcelona City Council. Throughout its history it has interacted with projects and milestones including 1000 Genomes Project, ENCODE Project, Cancer Genome Atlas, and collaborations with consortia such as ELIXIR, BioMed X, and European Molecular Biology Organization.

Mission and Research Areas

The institute’s mission encompasses basic and translational research bridging molecular mechanisms and disease models, aligning with research strands practiced at Francis Crick Institute, Cold Spring Harbor Laboratory, Sanger Institute, Broad Institute, and Memorial Sloan Kettering Cancer Center. Core research areas include genomics, transcriptomics, epigenomics, single-cell biology, and bioinformatics, analogous to programs at European Bioinformatics Institute, Palo Alto Genomics Research Center, Wellcome Sanger Institute, and National Institutes of Health. Focus areas address cancer, developmental biology, neurodegeneration, and infectious disease, intersecting with initiatives such as International Cancer Genome Consortium, Alzheimer's Disease Research Centers, Global Health Innovative Technology Fund, and European Lead Factory.

Organization and Leadership

The institute is governed by a management structure comparable to governance at Max Planck Institute for Molecular Genetics, Karolinska Institutet, Imperial College London, and University of Barcelona. Leadership roles mirror positions found at European Molecular Biology Laboratory and Spanish National Cancer Research Centre, coordinating research units, technology platforms, and administrative services. Scientific advisory boards often include representatives from institutions like Harvard Medical School, Massachusetts Institute of Technology, Stanford University School of Medicine, University of Cambridge, and Yale School of Medicine to guide strategy and evaluation.

Facilities and Resources

Facilities include high-throughput sequencing platforms similar to those at Sanger Institute and Broad Institute, cryo-electron microscopy infrastructure akin to MRC Laboratory of Molecular Biology, and advanced microscopy comparable to Max Planck Institute for Biophysical Chemistry and European Synchrotron Radiation Facility. Computational resources integrate practices from European Bioinformatics Institute, National Center for Biotechnology Information, and Supercomputing Wales, supporting workflows for single-cell RNA-seq, ChIP-seq, and long-read sequencing technologies like Oxford Nanopore Technologies and Pacific Biosciences. Biobank and model organism platforms reflect capabilities seen at Jackson Laboratory and Zebrafish International Resource Center.

Collaborations and Partnerships

The institute partners with universities and research centers such as Pompeu Fabra University, University of Barcelona, Hospital del Mar Research Institute, and international partners including Cold Spring Harbor Laboratory, Wellcome Trust Sanger Institute, Broad Institute, European Molecular Biology Laboratory, and Institut Pasteur. It participates in consortia like ELIXIR, Human Cell Atlas, International Cancer Genome Consortium, and engages with industry partners comparable to Roche, Illumina, Novartis, GlaxoSmithKline, and Sanofi for translational projects and technology transfer offices similar to those at EMBL Technology Transfer.

Education and Training

Training programs include PhD and postdoctoral fellowships modeled after schemes at Marie Skłodowska-Curie Actions, EMBO Fellowship, Human Frontier Science Program, and institutional doctoral programs like those at Barcelona Graduate School of Economics and BIST Graduate Program. The institute offers courses and workshops akin to offerings from Cold Spring Harbor Laboratory, Wellcome Genome Campus Advanced Courses, and summer schools comparable to EMBL Course and Conference Programme, facilitating exchange with clinical partners such as Vall d'Hebron University Hospital and Hospital Clínic de Barcelona.

Notable Research and Impact

Research outputs span discoveries in gene regulation, chromatin dynamics, single-cell analysis, and disease mechanisms with impact comparable to studies from ENCODE Project, Roadmap Epigenomics Consortium, Human Cell Atlas, and major publications in journals like Nature, Science, Cell, Nature Genetics, and Genome Research. Translational successes include biomarker identification and preclinical models that align with translational pipelines at European Institute of Oncology, Centre Léon Bérard, and collaborations with biotech spin-offs similar to Cellectis and CRISPR Therapeutics. The institute’s contributions influence policy and research funding discussions involving European Commission, Ministerio de Ciencia e Innovación (Spain), and regional bodies such as Generalitat de Catalunya.

Category:Research institutes in Spain